Michael R. Myers

Person

Fishers, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of AKT (protein kinase B)
- Patent number 7,998,977
- Issue date Aug 16, 2011
- Eli Lilly and Company
- Sajan Joseph
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors
- Patent number 7,652,015
- Issue date Jan 26, 2010
- Eli Lilly and Company
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted oxoazaheterocyclyl compounds
- Patent number 7,612,075
- Issue date Nov 3, 2009
- Aventis Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 7,550,597
- Issue date Jun 23, 2009
- Aventis Pharmaceuticals, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adenosine analogues and their use as pharmaceutical agents
- Patent number 7,265,111
- Issue date Sep 4, 2007
- Sanofi-Aventis Deutschland GmbH
- Antony Bigot
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,852,712
- Issue date Feb 8, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,846,815
- Issue date Jan 25, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,821,962
- Issue date Nov 23, 2004
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,696,434
- Issue date Feb 24, 2004
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Patent number 6,645,969
- Issue date Nov 11, 2003
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having antihypertensive, cardioprotective anti-ischemic a...
- Patent number 6,559,313
- Issue date May 6, 2003
- Aventis Pharma Deutschland GmbH
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,528,526
- Issue date Mar 4, 2003
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,524,347
- Issue date Feb 25, 2003
- Avantis Pharmaceuticals Inc.
- Michael. R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,482,834
- Issue date Nov 19, 2002
- Aventis Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having antihypertensive, cardioprotective, anti-ischemic...
- Patent number 6,376,472
- Issue date Apr 23, 2002
- Aventis Pharmaceuticals, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Patent number RE37650
- Issue date Apr 9, 2002
- Aventis Pharmacetical Products, Inc.
- Michael R. Myers
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,245,760
- Issue date Jun 12, 2001
- Aventis Pharmaceuticals Products, Inc
- Wei He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,180,632
- Issue date Jan 30, 2001
- Aventis Pharmaceuticals Products Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,159,978
- Issue date Dec 12, 2000
- Aventis Pharmaceuticals Product, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...
- Patent number 6,057,320
- Issue date May 2, 2000
- Aventis Pharmaceuticals Products Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...
- Patent number RE36256
- Issue date Jul 20, 1999
- Rhone-Poulenc Rorer Pharmaceuticals, Inc.
- Alfred P. Spada
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...
- Patent number 5,795,889
- Issue date Aug 18, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having antihypertensive, cardioprotective, anti-ischemic...
- Patent number 5,736,554
- Issue date Apr 7, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds h...
- Patent number 5,721,237
- Issue date Feb 24, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Patent number 5,714,493
- Issue date Feb 3, 1998
- Rhone-Poulenc Rorer Pharmaceuticals, Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or...
- Patent number 5,710,158
- Issue date Jan 20, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...
- Patent number 5,656,643
- Issue date Aug 12, 1997
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use t...
- Patent number 5,652,366
- Issue date Jul 29, 1997
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...
- Patent number 5,646,153
- Issue date Jul 8, 1997
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having antihypertensive, cardioprotective, anti-ischemic...
- Patent number 5,561,134
- Issue date Oct 1, 1996
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF AKT (PROTEIN KINASE B)
- Publication number 20090221633
- Publication date Sep 3, 2009
- Sajan Joseph
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase Inhibitors
- Publication number 20080269244
- Publication date Oct 30, 2008
- Jolie Anne Bastian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-vascular and anti-proliferation methods, therapies, and combin...
- Publication number 20070197538
- Publication date Aug 23, 2007
- Mark Nesbit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20050182054
- Publication date Aug 18, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel adenosine analogues and their use as pharmaceutical agents
- Publication number 20040127434
- Publication date Jul 1, 2004
- Antony Bigot
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted oxoazaheterocyclyl compounds
- Publication number 20040102450
- Publication date May 27, 2004
- Aventis Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Publication number 20040014774
- Publication date Jan 22, 2004
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating insulin resistance syndrome and diabetes
- Publication number 20030176390
- Publication date Sep 18, 2003
- Andreas Herling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030144284
- Publication date Jul 31, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030139399
- Publication date Jul 24, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030139400
- Publication date Jul 24, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030130285
- Publication date Jul 10, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds having antihypertensive, cardioprotective anti-ischemic a...
- Publication number 20020099030
- Publication date Jul 25, 2002
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20010023250
- Publication date Sep 20, 2001
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY

Michael R. Myers

Person

Patents Grantslast 30 patents

Inhibitors of AKT (protein kinase B)

Kinase inhibitors

Substituted oxoazaheterocyclyl compounds

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Adenosine analogues and their use as pharmaceutical agents

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Compounds having antihypertensive, cardioprotective anti-ischemic a...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Compounds having antihypertensive, cardioprotective, anti-ischemic...

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...

Compounds having antihypertensive, cardioprotective, anti-ischemic...

Protein tyrosine kinase aryl and heteroaryl quinazoline compounds h...

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or...

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...

DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use t...

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...

Compounds having antihypertensive, cardioprotective, anti-ischemic...

Patents Applicationslast 30 patents

INHIBITORS OF AKT (PROTEIN KINASE B)

Kinase Inhibitors

Anti-vascular and anti-proliferation methods, therapies, and combin...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Novel adenosine analogues and their use as pharmaceutical agents

Substituted oxoazaheterocyclyl compounds

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Methods of treating insulin resistance syndrome and diabetes

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Compounds having antihypertensive, cardioprotective anti-ischemic a...

Quinoline and quinoxaline compounds which inhibit platelet-derived...